1. Home
  2. IE vs SUPN Comparison

IE vs SUPN Comparison

Compare IE & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ivanhoe Electric Inc.

IE

Ivanhoe Electric Inc.

HOLD

Current Price

$19.13

Market Cap

2.5B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.07

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IE
SUPN
Founded
2020
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
IE
SUPN
Price
$19.13
$49.07
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$18.50
$61.60
AVG Volume (30 Days)
1.7M
609.1K
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,680,000.00
$681,539,000.00
Revenue This Year
$26.75
$8.32
Revenue Next Year
$27.74
$23.64
P/E Ratio
N/A
N/A
Revenue Growth
13.58
4.54
52 Week Low
$4.50
$29.16
52 Week High
$19.37
$57.65

Technical Indicators

Market Signals
Indicator
IE
SUPN
Relative Strength Index (RSI) 67.90 46.21
Support Level $17.10 $48.84
Resistance Level $18.58 $50.55
Average True Range (ATR) 1.07 1.64
MACD 0.09 -0.30
Stochastic Oscillator 90.97 32.02

Price Performance

Historical Comparison
IE
SUPN

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: